448 related articles for article (PubMed ID: 26797041)
1. Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease.
Osborn LM; Kamphuis W; Wadman WJ; Hol EM
Prog Neurobiol; 2016 Sep; 144():121-41. PubMed ID: 26797041
[TBL] [Abstract][Full Text] [Related]
2. Ca(2+) -dependent endoplasmic reticulum stress correlates with astrogliosis in oligomeric amyloid β-treated astrocytes and in a model of Alzheimer's disease.
Alberdi E; Wyssenbach A; Alberdi M; Sánchez-Gómez MV; Cavaliere F; Rodríguez JJ; Verkhratsky A; Matute C
Aging Cell; 2013 Apr; 12(2):292-302. PubMed ID: 23409977
[TBL] [Abstract][Full Text] [Related]
3. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
[TBL] [Abstract][Full Text] [Related]
4. The difference in gliosis induced by β-amyloid and Tau treatments in astrocyte cultures derived from senescence accelerated and normal mouse strains.
Lü L; Mak YT; Fang M; Yew DT
Biogerontology; 2009 Dec; 10(6):695-710. PubMed ID: 19221889
[TBL] [Abstract][Full Text] [Related]
5. Astroglia in dementia and Alzheimer's disease.
Rodríguez JJ; Olabarria M; Chvatal A; Verkhratsky A
Cell Death Differ; 2009 Mar; 16(3):378-85. PubMed ID: 19057621
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease:
Bronzuoli MR; Facchinetti R; Steardo L; Romano A; Stecca C; Passarella S; Steardo L; Cassano T; Scuderi C
Oxid Med Cell Longev; 2018; 2018():4720532. PubMed ID: 29576849
[TBL] [Abstract][Full Text] [Related]
7. Astrocyte Reactivity in Alzheimer's Disease: Therapeutic Opportunities to Promote Repair.
Mirzaei N; Davis N; Chau TW; Sastre M
Curr Alzheimer Res; 2022; 19(1):1-15. PubMed ID: 34719372
[TBL] [Abstract][Full Text] [Related]
8. Selective Ablation of
Baier MP; Nagaraja RY; Yarbrough HP; Owen DB; Masingale AM; Ranjit R; Stiles MA; Murphy A; Agbaga MP; Ahmad M; Sherry DM; Kinter MT; Van Remmen H; Logan S
J Neurosci; 2022 Aug; 42(31):5992-6006. PubMed ID: 35760531
[TBL] [Abstract][Full Text] [Related]
9. Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes.
Valenza M; Facchinetti R; Menegoni G; Steardo L; Scuderi C
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921556
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of the pore-forming K
Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
[TBL] [Abstract][Full Text] [Related]
11. The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease.
Duffy AM; Hölscher C
Neuroscience; 2013 Jan; 228():294-300. PubMed ID: 23103794
[TBL] [Abstract][Full Text] [Related]
12. The contribution of astrocytes to Alzheimer's disease.
Birch AM
Biochem Soc Trans; 2014 Oct; 42(5):1316-20. PubMed ID: 25233409
[TBL] [Abstract][Full Text] [Related]
13. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
Assefa BT; Gebre AK; Altaye BM
Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
[TBL] [Abstract][Full Text] [Related]
14. SVCT2 Expression and Function in Reactive Astrocytes Is a Common Event in Different Brain Pathologies.
Salazar K; Martínez F; Pérez-Martín M; Cifuentes M; Trigueros L; Ferrada L; Espinoza F; Saldivia N; Bertinat R; Forman K; Oviedo MJ; López-Gambero AJ; Bonansco C; Bongarzone ER; Nualart F
Mol Neurobiol; 2018 Jul; 55(7):5439-5452. PubMed ID: 28942474
[TBL] [Abstract][Full Text] [Related]
15. Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease.
Kumar A; Fontana IC; Nordberg A
J Neurochem; 2023 Feb; 164(3):309-324. PubMed ID: 34931315
[TBL] [Abstract][Full Text] [Related]
16. Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.
Smit T; Deshayes NAC; Borchelt DR; Kamphuis W; Middeldorp J; Hol EM
Glia; 2021 Aug; 69(8):1852-1881. PubMed ID: 33634529
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Astrocyte-Neuronal Communication in Alzheimer's Disease.
Nanclares C; Baraibar AM; Araque A; Kofuji P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360652
[TBL] [Abstract][Full Text] [Related]
18. Astroglial atrophy in Alzheimer's disease.
Verkhratsky A; Rodrigues JJ; Pivoriunas A; Zorec R; Semyanov A
Pflugers Arch; 2019 Oct; 471(10):1247-1261. PubMed ID: 31520182
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes in Alzheimer's disease: emerging roles in calcium dysregulation and synaptic plasticity.
Vincent AJ; Gasperini R; Foa L; Small DH
J Alzheimers Dis; 2010; 22(3):699-714. PubMed ID: 20847426
[TBL] [Abstract][Full Text] [Related]
20. The dual role of astrocyte activation and reactive gliosis.
Pekny M; Wilhelmsson U; Pekna M
Neurosci Lett; 2014 Apr; 565():30-8. PubMed ID: 24406153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
